The North America Medical Electrodes Market should witness market growth of 2.7% CAGR during the forecast period (2022-2028).
Electrophysiological (EP) signals are what cause the majority of human bodily movements (EEG). EP signals have generated a lot of academic interest due to the extensive information that can be retrieved from them, and they are frequently employed in HMI and healthcare monitoring. Electrocardiography (ECG), Electroencephalography (EEG), Electrooculography (EOG), and Electromyography (EMG), signals are among the main signals.
This may represent the physiological condition of the body and is an important marker for assessing the body's many physiological processes during clinical treatment, physical condition improvement, behavioral analysis, etc. Among these, the ECG signal serves as a gauge for detecting cardiovascular disorders such as arrhythmias and faulty valves because it immediately reflects the condition of the heart.
Important medical data about brain conditions like dementia, malignancies, and epilepsy can be obtained from EEG waves. Eye movement control and Mobile eye therapy are made possible by the ability of EOG signals to track the status of eye movement for monitoring sleep or retinal feedback. EMG signals have recently been extensively used in gesture detection and prosthesis control. They are intimately tied to muscle illness and tiredness.
According to the trends, the total prevalence of chronic diseases is increasing throughout this region. The top health concerns in the United States are coronary heart disease, respiratory diseases, cancer, stroke, Alzheimer's disease, injuries, diabetes, pneumonia and influenza, renal disease, and septicemia. These problems are going to get worse as the population of the country continues to get older, as current risk factors (bad diet, smoking, and a lack of physical activity) remain, and as medical developments continue to increase.
The US market dominated the North America Medical Electrodes Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $557 Million by 2028.The Canada market is poised to grow at a CAGR of 5% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 4.1% during (2022-2028).
Based on Product Type, the market is segmented into Surface Electrodes and Needle Electrodes. Based on Modality, the market is segmented into Electrocardiography (ECG), Electroencephalography (EEG), Electromyography (EMG), Brainstem Auditory Evoked Potentials (BAEPs) and Others. Based on Application, the market is segmented into Cardiology, Neurophysiology, Electrosurgery, Intraoperative Monitoring (IOM) and Sleep Study. Based on Cardiology Type, the market is segmented into Stress Test ECG, Neonatal ECG, Long-term Monitoring ECG, Short-term Monitoring ECG and Resting ECG. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Medtronic PLC, Koninklijke Philips N.V., ConMed Corporation, Becton, Dickinson and Company, Natus Medical Incorporated, Ambu A/S, Cognionics, Inc., CooperSurgical, Inc., and Dymedix Diagnostics.
Electrophysiological (EP) signals are what cause the majority of human bodily movements (EEG). EP signals have generated a lot of academic interest due to the extensive information that can be retrieved from them, and they are frequently employed in HMI and healthcare monitoring. Electrocardiography (ECG), Electroencephalography (EEG), Electrooculography (EOG), and Electromyography (EMG), signals are among the main signals.
This may represent the physiological condition of the body and is an important marker for assessing the body's many physiological processes during clinical treatment, physical condition improvement, behavioral analysis, etc. Among these, the ECG signal serves as a gauge for detecting cardiovascular disorders such as arrhythmias and faulty valves because it immediately reflects the condition of the heart.
Important medical data about brain conditions like dementia, malignancies, and epilepsy can be obtained from EEG waves. Eye movement control and Mobile eye therapy are made possible by the ability of EOG signals to track the status of eye movement for monitoring sleep or retinal feedback. EMG signals have recently been extensively used in gesture detection and prosthesis control. They are intimately tied to muscle illness and tiredness.
According to the trends, the total prevalence of chronic diseases is increasing throughout this region. The top health concerns in the United States are coronary heart disease, respiratory diseases, cancer, stroke, Alzheimer's disease, injuries, diabetes, pneumonia and influenza, renal disease, and septicemia. These problems are going to get worse as the population of the country continues to get older, as current risk factors (bad diet, smoking, and a lack of physical activity) remain, and as medical developments continue to increase.
The US market dominated the North America Medical Electrodes Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $557 Million by 2028.The Canada market is poised to grow at a CAGR of 5% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 4.1% during (2022-2028).
Based on Product Type, the market is segmented into Surface Electrodes and Needle Electrodes. Based on Modality, the market is segmented into Electrocardiography (ECG), Electroencephalography (EEG), Electromyography (EMG), Brainstem Auditory Evoked Potentials (BAEPs) and Others. Based on Application, the market is segmented into Cardiology, Neurophysiology, Electrosurgery, Intraoperative Monitoring (IOM) and Sleep Study. Based on Cardiology Type, the market is segmented into Stress Test ECG, Neonatal ECG, Long-term Monitoring ECG, Short-term Monitoring ECG and Resting ECG. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include 3M Company, Medtronic PLC, Koninklijke Philips N.V., ConMed Corporation, Becton, Dickinson and Company, Natus Medical Incorporated, Ambu A/S, Cognionics, Inc., CooperSurgical, Inc., and Dymedix Diagnostics.
Scope of the Study
By Product Type
- Surface Electrodes
- Needle Electrodes
By Modality
- Electrocardiography (ECG)
- Electroencephalography (EEG)
- Electromyography (EMG)
- Brainstem Auditory Evoked Potentials (BAEPs)
- Others
By Application
- Cardiology
- Stress Test ECG
- Neonatal ECG
- Long-term Monitoring ECG
- Short-term Monitoring ECG
- Resting ECG
- Neurophysiology
- Electrosurgery
- Intraoperative Monitoring (IOM)
- Sleep Study
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- 3M Company
- Medtronic PLC
- Koninklijke Philips N.V.
- ConMed Corporation
- Becton, Dickinson and Company
- Natus Medical Incorporated
- Ambu A/S
- Cognionics, Inc.
- CooperSurgical, Inc.
- Dymedix Diagnostics
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. North America Medical Electrodes Market by Product Type
Chapter 4. North America Medical Electrodes Market by Modality
Chapter 5. North America Medical Electrodes Market by Application
Chapter 6. North America Medical Electrodes Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- 3M Company
- Medtronic PLC
- Koninklijke Philips N.V.
- ConMed Corporation
- Becton, Dickinson and Company
- Natus Medical Incorporated
- Ambu A/S
- Cognionics, Inc.
- CooperSurgical, Inc.,
- Dymedix Diagnostics
Methodology
LOADING...
